Signal active
Contact Information
Social
Primary Organization
2020
11-50
Biotechnology, Life Science, Health Care, Medical, Biopharma
Bio
Harvey Berger is the Chairman, President and Chief Executive Officer of Kojin Therapeutics. He previously worked at ARIAD Pharmaceuticals as a Chairman and Chief Executive Officer Emeritus. Harvey Berger attended Colgate University.
Location
Palm Beach, Florida, United States, North America
Jobs history
12
Kojin Therapeutics
Chairman, President, & Chief Executive Officer
2024 - Current
The Fenn School
Trustee
1993 - 2000
Whitehead Institute for Biomedical Research
Trustee
1997 - 2008
Yale University School of Medicine
Dean’s Council
2011 - 2017
Concord Academy
Trustee
2018 - Current
The Cameron Boyce Foundation
Trustee
2021 - Current
Yale University School of Medicine
Associate Professor
Invalid date - Invalid date
Emory University School of Medicine
Professor
Invalid date - Invalid date
University of Pennsylvania
Adjunct Professor
Invalid date - Invalid date
American Heart Association
Established Investigator
Invalid date - Invalid date
CEO Network Partners
Advisor
2015 - 2018
Centocor Ortho Biotech
President, R&D
1986 - 1991
Educations
2
Yale University School of Medicine
Medicine
Colgate University
Biochemistry
Profile Resume
Harvey Berger is the Chairman, President, & Chief Executive Officer at Kojin Therapeutics, based in United States, North America. With a background in Biotechnology, Harvey Berger has a rich history of leadership and innovation.Harvey Berger studied MD Medicine at Yale University School of Medicine. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Products and Innovations
0
There is no product and inovations for this profile.
Achievements
0
There is no Achievements for this profile.
Publications
0
There is no publication for this profile.
Recent Activity
There is no recent news or activity for this profile.